Emily Pimblett, CHIEF ACCOUNTING OFFICER at Climb Bio, Inc. (CLYM), sold 1,235 shares at $2.02 ($2K) on 2024-12-19, disclosed to the SEC on 2024-12-20.
Scheduled sale ($2k) by CHIEF ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ELYM | SELL | 2024-09-20 | $10K | — | Filing → |
| ELYM | SELL | 2024-06-21 | $9K | — | Filing → |